http://www.proseedcapital.com/en Thu, 31 Dec 2009 01:52:28 +0000 http://wordpress.org/?v=2.9.1 en hourly 1 http://www.proseedcapital.com/en/2009/12/egalet-and-redhill-biopharma-enter-into-an-exclusive-license-agreement/ http://www.proseedcapital.com/en/2009/12/egalet-and-redhill-biopharma-enter-into-an-exclusive-license-agreement/#comments Thu, 31 Dec 2009 01:52:28 +0000 admin http://www.proseedcapital.com/en/?p=91 http://www.proseedcapital.com/en/2009/12/egalet-and-redhill-biopharma-enter-into-an-exclusive-license-agreement/feed/ 0 http://www.proseedcapital.com/en/2009/06/lifeline-scientific-inc-trial-results-published-at-american-transplant-congress/ http://www.proseedcapital.com/en/2009/06/lifeline-scientific-inc-trial-results-published-at-american-transplant-congress/#comments Sun, 28 Jun 2009 02:46:07 +0000 admin http://www.proseedcapital.com/en/?p=52 http://www.proseedcapital.com/en/2009/06/lifeline-scientific-inc-trial-results-published-at-american-transplant-congress/feed/ 0 http://www.proseedcapital.com/en/2009/04/amarins-amr101-for-huntingtons-disease-marketing-authorization-application-accepted-for-review-by-emea/ http://www.proseedcapital.com/en/2009/04/amarins-amr101-for-huntingtons-disease-marketing-authorization-application-accepted-for-review-by-emea/#comments Wed, 08 Apr 2009 12:57:28 +0000 admin http://www.proseedcapital.com/en/?p=78 http://www.proseedcapital.com/en/2009/04/amarins-amr101-for-huntingtons-disease-marketing-authorization-application-accepted-for-review-by-emea/feed/ 0 http://www.proseedcapital.com/en/2008/07/amarin-proceeding-to-phase-3-with-amr101-for-hypertriglyceridemia/ http://www.proseedcapital.com/en/2008/07/amarin-proceeding-to-phase-3-with-amr101-for-hypertriglyceridemia/#comments Wed, 23 Jul 2008 02:55:14 +0000 admin http://www.proseedcapital.com/en/?p=58 http://www.proseedcapital.com/en/2008/07/amarin-proceeding-to-phase-3-with-amr101-for-hypertriglyceridemia/feed/ 0 http://www.proseedcapital.com/en/2008/06/lifeline-wins-contracts-to-supply-largest-canadian-transplant-programmes/ http://www.proseedcapital.com/en/2008/06/lifeline-wins-contracts-to-supply-largest-canadian-transplant-programmes/#comments Tue, 10 Jun 2008 02:57:37 +0000 admin http://www.proseedcapital.com/en/?p=60 http://www.proseedcapital.com/en/2008/06/lifeline-wins-contracts-to-supply-largest-canadian-transplant-programmes/feed/ 0 http://www.proseedcapital.com/en/2008/04/kamada-announces-that-it-had-succesfully-met-the-primary-endpoint-in-its-us-phase-iii-clinical-trial-with-intravenous-aat/ http://www.proseedcapital.com/en/2008/04/kamada-announces-that-it-had-succesfully-met-the-primary-endpoint-in-its-us-phase-iii-clinical-trial-with-intravenous-aat/#comments Thu, 03 Apr 2008 02:58:49 +0000 admin http://www.proseedcapital.com/en/?p=63 http://www.proseedcapital.com/en/2008/04/kamada-announces-that-it-had-succesfully-met-the-primary-endpoint-in-its-us-phase-iii-clinical-trial-with-intravenous-aat/feed/ 0 http://www.proseedcapital.com/en/2008/03/lifeline-division-wins-contracts-to-supply-two-leading-transplant-centres/ http://www.proseedcapital.com/en/2008/03/lifeline-division-wins-contracts-to-supply-two-leading-transplant-centres/#comments Tue, 11 Mar 2008 02:59:42 +0000 admin http://www.proseedcapital.com/en/?p=65 http://www.proseedcapital.com/en/2008/03/lifeline-division-wins-contracts-to-supply-two-leading-transplant-centres/feed/ 0 http://www.proseedcapital.com/en/2008/01/amarin-to-commence-phase-ii-trial-with-amr101-in-age-associated-memory-impairment/ http://www.proseedcapital.com/en/2008/01/amarin-to-commence-phase-ii-trial-with-amr101-in-age-associated-memory-impairment/#comments Fri, 11 Jan 2008 03:00:37 +0000 admin http://www.proseedcapital.com/en/?p=67 http://www.proseedcapital.com/en/2008/01/amarin-to-commence-phase-ii-trial-with-amr101-in-age-associated-memory-impairment/feed/ 0 http://www.proseedcapital.com/en/2008/01/lifeline-scientific-announces-successful-completion-of-ipo/ http://www.proseedcapital.com/en/2008/01/lifeline-scientific-announces-successful-completion-of-ipo/#comments Wed, 09 Jan 2008 03:01:22 +0000 admin http://www.proseedcapital.com/en/?p=69 http://www.proseedcapital.com/en/2008/01/lifeline-scientific-announces-successful-completion-of-ipo/feed/ 0 http://www.proseedcapital.com/en/2007/12/amarin-acquires-ester-neurosciences/ http://www.proseedcapital.com/en/2007/12/amarin-acquires-ester-neurosciences/#comments Thu, 06 Dec 2007 03:02:00 +0000 admin http://www.proseedcapital.com/en/?p=71 http://www.proseedcapital.com/en/2007/12/amarin-acquires-ester-neurosciences/feed/ 0